[144] Silicon Laboratories Inc SEC Filing

Rhea-AI Filing Summary

Form 144 filing for Silicon Laboratories, Inc. (SLAB) documents a proposed sale of 1,800 common shares through Fidelity Brokerage Services on 08/29/2025 with an aggregate market value of $240,426.18. The filing states the shares were acquired via an option granted 01/28/2016 and payment is by cash. The issuer's reported number of shares outstanding is 32,815,310. The filer, identified by name in past sales, sold 2,270 shares on 08/19/2025 for $301,206.53 and 8,000 shares on 08/22/2025 for $1,161,817.60. The notice includes the required representation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider disposing of equity via Rule 144; recent sales total 12,070 shares, representing a de minimis portion of outstanding stock.

The filing reports a proposed sale of 1,800 common shares on 08/29/2025 with an aggregate market value of $240,426.18, following two recent open-market sales of 2,270 and 8,000 shares that generated $301,206.53 and $1,161,817.60 respectively. Against the issuer's stated 32,815,310 shares outstanding, the combined activity (12,070 shares) is a very small fraction of the float. From a market-impact perspective, these transactions are routine insider liquidity events executed through Fidelity and documented under Rule 144; they do not by themselves indicate a material change to company fundamentals.

Corporate Governance Expert

TL;DR: Filing complies with Rule 144 disclosure; seller attests no undisclosed material adverse information.

The notice discloses the source of the shares as an option grant dated 01/28/2016 and confirms cash payment upon sale. It includes the standard attestation about the absence of undisclosed material adverse information and the required signature warning. Procedurally, the filing meets Rule 144 requirements by listing recent sales, broker details, and outstanding shares. There is no disclosure here of any new governance or regulatory issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1800	240426.18	32815310	08/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/29/2025	Option Granted - 01/28/2016	Issuer			1800	08/29/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Brandon Tolany 400 West Cesar Chavez Austin TX 78701	Common	08/19/2025	2270	301206.53
Brandon Tolany 400 West Cesar Chavez Austin TX 78701	Common	08/22/2025	8000	1161817.60

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for SLAB disclose about the proposed sale?

The filing discloses a proposed sale of 1,800 common shares via Fidelity on 08/29/2025 with aggregate market value of $240,426.18.

Who previously sold SLAB shares for the account mentioned in this Form 144?

Brandon Tolany sold 2,270 shares on 08/19/2025 for $301,206.53 and 8,000 shares on 08/22/2025 for $1,161,817.60.

How were the 1,800 shares being sold acquired according to the filing?

The shares were acquired through an option granted on 01/28/2016, with the acquisition date listed as 08/29/2025, and payment on sale is by cash.

How many shares outstanding does the filing report for the issuer?

The filing reports 32,815,310 shares outstanding for the issuer.

Does the filer certify there is no undisclosed material information?

Yes, the notice includes the seller's representation that they do not know any material adverse information about the issuer that has not been publicly disclosed.